technology

Imperagen Secures £5 Million to Advance Quantum Physics and AI in Enzyme Engineering

21 Mayıs 2026TechCrunch

Imperagen, a biotech firm, has successfully raised £5 million ($6.7 million) in a seed funding round. The investment was led by PXN Ventures, with additional contributions from IQ Capital and Northern Gritstone.
The company aims to leverage quantum physics and artificial intelligence to advance enzyme engineering.
The funding landscape for biotech companies has been increasingly competitive, with investors keen to support innovative technologies that promise to revolutionize traditional industries. Imperagen's focus on enzyme engineering through quantum and AI technologies places it in a unique niche that could attract furthe…
The infusion of £5 million into Imperagen highlights the growing interest in the intersection of biotechnology and advanced computational methods. By harnessing quantum physics and AI, Imperagen is positioning itself at the forefront of enzyme engineering, which could lead to significant advancements in various appl…

NewsAI özeti

This article is for informational purposes only and does not constitute financial advice.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.